Latest Shareholder Benefits News

Vulcan Steel has successfully closed its entitlement offer, raising A$87.1 million to fund the strategic acquisition of Roofing Industries Limited. The retail shortfall bookbuild sold shares at a premium, rewarding shareholders who did not fully participate.

Washington H. Soul Pattinson has released comprehensive rules for its Dividend Reinvestment Plan, clarifying shareholder eligibility, participation options, and share allocation procedures.

Evolution Mining Limited has confirmed its fully franked dividend of AUD 0.13 per share for the first half of FY25, alongside final details of its dividend reinvestment plan pricing and terms.

Duxton Water Limited has declared its 17th consecutive dividend increase at 3.72 cents per share, fully franked, while removing the discount on its Dividend Reinvestment Plan following a major debt repayment.

Harvey Norman Holdings Limited has announced a fully franked ordinary dividend of AUD 0.145 per share for the six months ending June 2025, signaling steady returns for shareholders.

Echelon Resources Limited reported a robust financial year ending June 2025, driven by strategic asset acquisitions and strong commodity prices, delivering a 34% revenue increase and a near 20-fold jump in net profit after tax.

Pinnacle Minerals Limited has launched a new options prospectus offering nearly 40 million options, potentially raising $3.18 million if exercised. The options carry an exercise price of $0.08 and expire in 2028, aiming to reward shareholders and fulfill placement obligations.

Infomedia Limited has struck a deal with TPG Capital Asia to be acquired at $1.72 per share, offering shareholders a 41% premium over recent trading prices. The scheme includes fully franked dividends, potentially raising the effective value to $1.74 per share for eligible investors.

Eastern Metals has agreed to sell its Browns Reef Project tenements to Australian Gold and Copper, offering shareholders an immediate benefit and ongoing exposure through share distribution.

Argo Investments Limited reported a modest profit increase for the fiscal year ending June 2025 and announced a fully franked final dividend, including a LIC capital gain component that offers tax benefits to shareholders.

Rhythm Biosciences has successfully validated its ColoSTAT® colorectal cancer test, secured its first strategic partnership for Genetype, and secured $1 million in non-dilutive funding, setting the stage for a transformative FY26.

Larvotto Resources has opened a $5 million Share Purchase Plan offering shares at a 13.5% discount to fund key development and exploration activities at its Hillgrove Project in NSW.